Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Name: Adaptive Biotechnologies Corp: Is Infosys Ltd. worth buying?
Item: Adaptive Biotechnologies Corp
Rating: 1.361277875
Author: Trendlyne DVM scores

Momentum Trap

about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

13.17 0.72 (5.78%)

36.56% Fall from 52W High

3.9M

XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

10.7 / 100

Technically Neutral

42.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 58%

7 analysts

Adaptive biotech Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

36.56% Fall from 52W High

SWOT Analysis

Adaptive biotech Corp Live Price Chart